Efficacy and safety of dexanabinol in severe traumatic brain injury: Results of a phase III randomised, placebo-controlled, clinical trial

Lancet Neurology

Volumn 5, Issue 1, 2006, Pages 38-45

  Maas, Andrew I R ^a   Murray, Gordon ^b   Henney III, Herbert ^c   Kassem, Nadim ^c   Legrand, Valerie ^d   Mangelus, Miriam ^c   Muizelaar, Jan Paul ^e   Stocchetti, Nino ^f   Knoller, Nachshon ^g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Pharmos Corporation   (United States)

^d IQVIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MILAN   (Italy)

^g SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXANABINOL; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; INJURY SCALE; INTRACRANIAL PRESSURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; NERVOUS SYSTEM INJURY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REFLEX RECRUITMENT; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HUMANS; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; ODDS RATIO; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TETRAHYDROCANNABINOL; TIME FACTORS; TREATMENT OUTCOME;

EID: 29044436727     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70253-2     Document Type: Article

References (33)

1. J Ghajar Traumatic brain injury Lancet 356 2000 923 929
2. DJ Thurman Epidemiology and economics of head injury Miller L Hayes R Head trauma: basic, preclinical, and clinical directions 2001 Wiley and Sons New York, USA
3. J Bruns Jr, WA Hauser The epidemiology of traumatic brain injury: a review Epilepsia 44 suppl 10 2003 2 10
4. AIR Maas, EW Steyerberg, GD Murray Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations Neurosurgery 44 1999 1286 1298
5. JJ Feigenbaum, F Bergman, SA Richmond Nonpsychotrophic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker Proc Natl Acad Sci USA 86 1989 9584 9587
6. N Eshar, S Striem, R Kohen Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist Eur J Pharmacol 283 1995 19 29
7. E Shohami, R Gallily, R Mechoulam Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNF-a inhibitor and an effective neuroprotectant J Neuroimmunol 72 1997 169 177
8. R Gallily, A Yamin, Y Waksman Protection against septic shock and surpression of tumor necrosis factor α and nitric oxide production by dexanabinol (HU-211), a non-psychotropic cannabinoid J Pharm Exp Ther 83 1997 1 7
9. E Shohami, M Novikov, R Bass Long-term effect of HU-211, a novel competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat Brain Research 674 1995 55 62
10. ME Brewster, E Pop, RL Foltz Clinical pharmacokinetics of escalating iv doses of dexanabinol (HU-211), a neuroprotectant agent, in normal volunteers Int J Clin Pharmacol Ther 535 1997 361 365
11. N Knoller, L Levi, I Shoshan Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo controlled, phase II clinical trial Crit Care Med 30 2002 548 554
12. LF Marshall, HD Eisenberg, JA Jane A new classification of head injury based on computerized tomography J Neurosurgery 75 1991 s14 s20
13. JM Evans, JA Keogh Adverse reactions to intravenous anaesthetic induction agents BMJ 2 1977 735 736
14. JG Theis, M Liau-Chu, HS Chan Anaphylactoid reactions in children receiving high dose cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of cremophor Eur J Clin Oncol 13 1995 2508 2516
15. A Marmarou, RL Anderson, JD Ward NINDS traumatic coma data bank: intracranial pressure monitoring methodology J Neurosurgery 75 1991 s21 s27
16. G Morris, N Juul, S Marshall Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries Neurosurgery 43 1998 1369 1374
17. MR Bullock, RM Chesnut, GL Clifton Part 1: guidelines for the management of severe traumatic brain injury J Neurotrauma 17 2000 449
18. AIR Maas, M Dearden, GM Teasdale EBIC guidelines for management of severe head injury in adults Acta Neurochirurgica 139 1997 286 294
19. JT Wilson, LE Pettigrew, GM Teasdale Structured interviews for the Glasgow outcome scale and the extended Glasgow coma scale: guidelines for their use J Neurotrauma 15 1998 573 585
20. C Collin, DT Wade, S Davis The Barthel ADL index: a reliability study Int Disabil Stud 10 1998 61 63
21. JE Ware, KK Snow, M Kosinski SF 36 health survey manual and interpretation guide 1993 The Health Institute, Nimrod Press Boston, USA
22. M Dijkers Measuring the long-term outcomes of traumatic brain injury: a review of the community integration questionnaire J Head Trauma Rehab 12 1997 74 91
23. GD Murray, D Barer, S Choi Design and analysis of phase III trials with ordered outcome scales: the concept of the Sliding Dichotomy J Neurotrauma 22 2005 511 517
24. C Hukkelhoven, EW Steyerberg, JDF Habbema Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics J Neurotrauma 22 2005 1025 1039
25. K Bolland, MR Sooriyarachchi, J Whitehead Sample size review in a head injury trial with ordered categorical responses Stat Med 17 1998 2835 2847
26. RK Narayan, ME Michel the Clinical Trials in Head Injury Study Group Clinical trials in head injury J Neurotrauma 19 2002 503 557
27. AIR Maas, A Marmarou, GD Murray Clinical trials in traumatic brain injury: current problems and future solutions Acta Neurochir 89 2004 113 118
28. K Dickinson, F Bunn, R Wentz Size and quality of randomized controlled trials in head injury: review of published studies BMJ 320 2000 1308 1311
29. JT Hoff Cerebral protection J Neurosurg 65 1986 579 591
30. H Bramlett, W Dietrich Pathophysiology of cerebral ischemia and brain trauma: similarities and differences J Cereb Blood Flow Metab 24 2004 133 150
31. SM Toutant, Mr Klauber, LF Marshall Absent or compressed basal cisterns on first CT scan: ominous predictors of outcome in severe head injury J Neurosurgery 61 1984 691 694
32. GL Clifton, ER Miller, SC Choi Lack of effect of induction of hypothermia after acute brain injury N Engl J Med 344 2001 556 563
33. M Wahl, L Schilling Regulation of cerebral blood flow-a brief review Acta Neurochir Suppl (Wien) 59 1993 3 10